Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Rafael Sanchez

Showing results (101-110 of 256) with videos related to

Pageof 26
Sort By:
Journal of Endourology|April 25, 2019
Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized MethodologyArnas Bakavicius, Rafael Sanchez-Salas, Fabio Muttin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 8, 2024
Prostate cancer detection rate with MRI-targeted biopsy alone using outpatient transperineal prostate biopsyPier Paolo Avolio, Toufic Hassan, Abdulmalik Addar, et al.
European Urology|December 26, 2012
Morbidity of focal therapy in the treatment of localized prostate cancerEric Barret, Youness Ahallal, Rafael Sanchez-Salas, et al.
The Canadian Journal of Urology|February 24, 2024
Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experienceIoana Fugaru, David Bouhadana, Gautier Marcq, et al.
The Journal of Urology|August 22, 2017
Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional OutcomesSilvia Garcia-Barreras, Rafael Sanchez-Salas, Arjun Sivaraman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2017
Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysisPaolo Capogrosso, Eric Barret, Rafael Sanchez-Salas, et al.
Urologic Oncology|April 1, 2017
Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade groupingGiorgio Gandaglia, R Jeffrey Karnes, Arjun Sivaraman, et al.
Archivos Espanoles De Urologia|February 15, 2013
Renal biopsies for small renal masses. For whom, when and howOleksandr Stakhovsky, Rafael Sanchez-Salas, Eric Barret, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2022
The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysisWilly Baccaglini, Antonio F Rodrigues, Saulo B Teles, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 18, 2022
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and SpainEmilio Arisi, Cosima Bauer, Manuela Farris, et al.
Pageof 26

Showing results (101-110 of 256) with videos related to

Sort By:
Pageof 26
Journal of Endourology|April 25, 2019
Comprehensive Evaluation of Focal Therapy Complications in Prostate Cancer: A Standardized MethodologyArnas Bakavicius, Rafael Sanchez-Salas, Fabio Muttin, et al.
Canadian Urological Association Journal = Journal De L'Association Des Urologues Du Canada|July 8, 2024
Prostate cancer detection rate with MRI-targeted biopsy alone using outpatient transperineal prostate biopsyPier Paolo Avolio, Toufic Hassan, Abdulmalik Addar, et al.
European Urology|December 26, 2012
Morbidity of focal therapy in the treatment of localized prostate cancerEric Barret, Youness Ahallal, Rafael Sanchez-Salas, et al.
The Canadian Journal of Urology|February 24, 2024
Partial gland ablation with high intensity focal ultrasound impact on genito-urinary function and quality of life: our initial experienceIoana Fugaru, David Bouhadana, Gautier Marcq, et al.
The Journal of Urology|August 22, 2017
Comparative Analysis of Partial Gland Ablation and Radical Prostatectomy to Treat Low and Intermediate Risk Prostate Cancer: Oncologic and Functional OutcomesSilvia Garcia-Barreras, Rafael Sanchez-Salas, Arjun Sivaraman, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|December 11, 2017
Oncological and functional outcomes of elderly men treated with HIFU vs. minimally invasive radical prostatectomy: A propensity score analysisPaolo Capogrosso, Eric Barret, Rafael Sanchez-Salas, et al.
Urologic Oncology|April 1, 2017
Are all grade group 4 prostate cancers created equal? Implications for the applicability of the novel grade groupingGiorgio Gandaglia, R Jeffrey Karnes, Arjun Sivaraman, et al.
Archivos Espanoles De Urologia|February 15, 2013
Renal biopsies for small renal masses. For whom, when and howOleksandr Stakhovsky, Rafael Sanchez-Salas, Eric Barret, et al.
Acta Oncologica (Stockholm, Sweden)|October 19, 2022
The current role of local treatment in metastatic prostate cancer: systematic review and meta-analysisWilly Baccaglini, Antonio F Rodrigues, Saulo B Teles, et al.
The European Journal of Contraception & Reproductive Health Care : the Official Journal of the European Society of Contraception|October 18, 2022
The views of women and pharmacists on the desirability of a progestogen-only pill over the counter. Results of a survey in Germany, Italy and SpainEmilio Arisi, Cosima Bauer, Manuela Farris, et al.
Pageof 26